vs
Amarin Corp plc(AMRN)与MERCANTILE BANK CORP(MBWM)财务数据对比。点击上方公司名可切换其他公司
MERCANTILE BANK CORP的季度营收约是Amarin Corp plc的1.5倍($67.6M vs $45.1M),MERCANTILE BANK CORP净利率更高(33.6% vs -23.3%,领先56.8%),过去两年MERCANTILE BANK CORP的营收复合增速更高(9.1% vs -18.3%)
Amarin是一家1993年成立的爱裔美籍生物制药企业,总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物,已推出处方级Omega-3脂肪酸药物Vascepa(AMR-101)。
泰米尔纳德商业银行(TMB)是一家印度银行,总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年,最初名为纳达尔银行,1962年11月更名为泰米尔纳德商业银行,以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
AMRN vs MBWM — 直观对比
营收规模更大
MBWM
是对方的1.5倍
$45.1M
净利率更高
MBWM
高出56.8%
-23.3%
两年增速更快
MBWM
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $45.1M | $67.6M |
| 净利润 | $-10.5M | $22.7M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | — |
| 净利率 | -23.3% | 33.6% |
| 营收同比 | 7.0% | — |
| 净利润同比 | 33.0% | 16.1% |
| 每股收益(稀释后) | — | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMRN
MBWM
| Q1 26 | $45.1M | $67.6M | ||
| Q4 25 | $49.2M | $62.1M | ||
| Q3 25 | $49.7M | $62.4M | ||
| Q2 25 | $72.7M | $60.9M | ||
| Q1 25 | $42.0M | $57.3M | ||
| Q4 24 | $62.3M | $58.5M | ||
| Q3 24 | $42.3M | $58.0M | ||
| Q2 24 | $67.5M | $56.8M |
净利润
AMRN
MBWM
| Q1 26 | $-10.5M | $22.7M | ||
| Q4 25 | $-1.2M | $22.8M | ||
| Q3 25 | $-7.7M | $23.8M | ||
| Q2 25 | $-14.1M | $22.6M | ||
| Q1 25 | $-15.7M | $19.5M | ||
| Q4 24 | $-48.6M | $19.6M | ||
| Q3 24 | $-25.1M | $19.6M | ||
| Q2 24 | $1.5M | $18.8M |
毛利率
AMRN
MBWM
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率
AMRN
MBWM
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 42.0% | ||
| Q3 25 | -22.4% | 44.0% | ||
| Q2 25 | -22.0% | 42.6% | ||
| Q1 25 | -39.9% | 42.0% | ||
| Q4 24 | -84.3% | 39.7% | ||
| Q3 24 | -59.5% | 42.4% | ||
| Q2 24 | -0.8% | 41.4% |
净利率
AMRN
MBWM
| Q1 26 | -23.3% | 33.6% | ||
| Q4 25 | -2.5% | 36.8% | ||
| Q3 25 | -15.6% | 38.1% | ||
| Q2 25 | -19.4% | 37.1% | ||
| Q1 25 | -37.4% | 34.1% | ||
| Q4 24 | -78.0% | 33.5% | ||
| Q3 24 | -59.4% | 33.8% | ||
| Q2 24 | 2.3% | 33.1% |
每股收益(稀释后)
AMRN
MBWM
| Q1 26 | — | $1.32 | ||
| Q4 25 | $0.00 | $1.41 | ||
| Q3 25 | $-0.02 | $1.46 | ||
| Q2 25 | $-0.03 | $1.39 | ||
| Q1 25 | $-0.04 | $1.21 | ||
| Q4 24 | $-0.12 | $1.20 | ||
| Q3 24 | $-0.06 | $1.22 | ||
| Q2 24 | $0.00 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | $1.5M |
| 股东权益账面价值 | — | $736.9M |
| 总资产 | $645.8M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势,按日历期对齐
现金及短期投资
AMRN
MBWM
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
总债务
AMRN
MBWM
| Q1 26 | — | $1.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
AMRN
MBWM
| Q1 26 | — | $736.9M | ||
| Q4 25 | $459.3M | $724.9M | ||
| Q3 25 | $458.9M | $657.6M | ||
| Q2 25 | $464.9M | $631.5M | ||
| Q1 25 | $473.7M | $608.3M | ||
| Q4 24 | $486.2M | $584.5M | ||
| Q3 24 | $531.4M | $583.3M | ||
| Q2 24 | $551.9M | $551.2M |
总资产
AMRN
MBWM
| Q1 26 | $645.8M | $6.9B | ||
| Q4 25 | $670.8M | $6.8B | ||
| Q3 25 | $659.8M | $6.3B | ||
| Q2 25 | $670.1M | $6.2B | ||
| Q1 25 | $655.7M | $6.1B | ||
| Q4 24 | $685.3M | $6.1B | ||
| Q3 24 | $750.6M | $5.9B | ||
| Q2 24 | $799.9M | $5.6B |
负债/权益比
AMRN
MBWM
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |